| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |